Cases 31 - 40 of 242
MERCK SHARP & DOHME B.V. et al v. MYLAN API US LLC et al
as 2:2020cv03270
Defendant:
MYLAN PHARMACEUTICALS INC., MYLAN INC. and MYLAN API US LLC
Plaintiff:
ORGANON USA INC. and MERCK SHARP & DOHME B.V.
Cause Of Action: 35 U.S.C. § 271
CELGENE CORPORATION v. MYLAN PHARMACEUTICALS INC. et al
as 2:2020cv02608
Plaintiff:
CELGENE CORPORATION
Defendant:
MYLAN PHARMACEUTICALS INC., MYLAN INC. and MYLAN N.V.
Cause Of Action: 15 U.S.C. § 1126
CUBIST PHARMACEUTICALS LLC v. MYLAN PHARMACEUTICALS INC. et al
as 3:2020cv03168
Plaintiff:
CUBIST PHARMACEUTICALS LLC
Defendant:
MYLAN INC., MYLAN PHARMACEUTICALS INC. and MYLAN N.V.
Cause Of Action: 35 U.S.C. § 271
CUBIST PHARMACEUTICALS LLC v. MYLAN PHARMACEUTICALS INC. et al
as 2:2020cv03168
Plaintiff:
CUBIST PHARMACEUTICALS LLC
Defendant:
MYLAN INC., MYLAN PHARMACEUTICALS INC. and MYLAN N.V.
Cause Of Action: 35 U.S.C. § 271
BAUSCH HEALTH US, LLC et al v. MYLAN PHARMACEUTICALS INC. et al
as 3:2020cv02749
Plaintiff:
BAUSCH HEALTH IRELAND LIMITED, KAKEN PHARMACEUTICAL CO., LTD., BAUSCH HEALTH US, LLC and others
Defendant:
MYLAN PHARMACEUTICALS INC., MYLAN INC. and MYLAN LABORATORIES LTD.
Cause Of Action: 35 U.S.C. § 271
Merck Sharp & Dohme Corp. v. Mylan Pharmaceuticals Inc. et al
as 1:2019cv01489
Defendant:
Mylan Pharmaceuticals Inc.
Plaintiff:
Merck Sharp & Dohme Corp.
Cause Of Action: 35 U.S.C. § 271
CELGENE CORPORATION v. MYLAN PHARMACEUTICALS INC. et al
as 2:2019cv22231
Plaintiff:
CELGENE CORPORATION
Defendant:
MYLAN PHARMACEUTICALS INC., MYLAN INC. and MYLAN N.V.
Cause Of Action: 15 U.S.C. § 1126
In re: Palbociclib Patent Litigation
as 1:2019md02912
Not Classified By Court:
Aizant Drug Research Solutions Pvt. Ltd., Hetero USA Inc., Teva Pharmaceuticals USA, Inc. and others
In Re:
In re: Palbociclib Patent Litigation
Cause Of Action: 35 U.S.C. § 271
Keryx Biopharmaceuticals, Inc et al v. Mylan Pharmaceuticals Inc.
as 1:2019cv01445
Plaintiff:
Panion & BF Biotech, Inc., Keryx Biopharmaceuticals, Inc. and Chen Hsing Hsu
Defendant:
Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
In re: Auryxia (Ferric Citrate) Patent Litigation
as 1:2019md02896
Not Classified By Court:
Chemo Research S.L., Insud Pharma S.L., Teva Pharmaceuticals USA, Inc. and others
Counter Defendant:
Keryx Biopharmaceuticals, Inc., Panion & BF Biotech, Inc. and Chen Hsing Hsu
Counter Claimant:
Lupin Atlantis Holdings SA and Lupin Ltd.
In Re:
In re: Auryxia (Ferric Citrate) Patent Litigation
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
